KAHR Bio

Modi'in Makabim-Re'ut, Israel · Founded 2005 · Privately Held (backing)

Developer of a cancer drug intended to activate immune responses by converting cancer camouflage into beacons for the immune system to attack. KAHR Bio is based in Modi'in Makabim-Re'ut, Israel and was founded in 2005. Its last reported valuation was $166 million in Nov 2022. It has raised $183 million.

Last reported valuation

$165.7M

Oct 2026

Priced at

—

Total raised

$183.3M

Last round

—

How much has KAHR Bio raised?

$183.3Macross 0 recorded rounds

Free account

More of KAHR Bio with a free account

·The complete investor list: 19 names
·Watch KAHR Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

KAHR Bio investors

19 investors are on record for KAHR Bio, including Korea Investment Partners, Innovation Authority, Peregrine Ventures and SPRIM Global Investments.

For fundraisers

Raising for a company like KAHR Bio?

19 investors have backed KAHR Bio.

See all 19 investors →

Frequently asked about KAHR Bio

How much has KAHR Bio raised?: KAHR Bio has raised $183.3M in total across 0 recorded funding rounds.